Double Medical Valuation
| 002901 Stock | 32.74 0.69 2.15% |
At this time, the firm appears to be overvalued. Double Medical Technology shows a prevailing Real Value of USD27.88 per share. The current price of the firm is USD32.74. Our model computes the value of Double Medical Technology from reviewing the firm fundamentals such as Profit Margin of 0.10 %, shares outstanding of 414.02 M, and Current Valuation of 12.38 B as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 4.1949 | Enterprise Value 12.4 B | Enterprise Value Ebitda 46.5141 | Price Sales 6.9447 | Trailing PE 67.6875 |
Overvalued
Today
Please note that Double Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Double Medical Technology is based on 3 months time horizon. Increasing Double Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Double Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Double Stock. However, Double Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 32.74 | Real 27.88 | Hype 33.85 |
The real value of Double Stock, also known as its intrinsic value, is the underlying worth of Double Medical Technology Company, which is reflected in its stock price. It is based on Double Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Double Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Double Medical Technology helps investors to forecast how Double stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Double Medical more accurately as focusing exclusively on Double Medical's fundamentals will not take into account other important factors: Double Medical Cash |
|
Double Medical Total Value Analysis
Double Medical Technology is presently forecasted to have takeover price of 12.38 B with market capitalization of 13.45 B, debt of 316.13 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Double Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.38 B | 13.45 B | 316.13 M |
Double Medical Investor Information
About 86.0% of the company shares are owned by insiders or employees . The book value of Double Medical was presently reported as 7.76. The company last dividend was issued on the 24th of June 2024. Based on the analysis of Double Medical's profitability, liquidity, and operating efficiency, Double Medical Technology is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 70.2 M | 73.9 M |
|
| |||||
| Operating Income | 107.9 M | 113.6 M |
|
|
Double Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Double Medical has an asset utilization ratio of 33.04 percent. This suggests that the Company is making USD0.33 for each dollar of assets. An increasing asset utilization means that Double Medical Technology is more efficient with each dollar of assets it utilizes for everyday operations.Double Medical Ownership Allocation
Double Medical holds a total of 414.02 Million outstanding shares. Double Medical Technology shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 86.31 percent of Double Medical Technology outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Double Medical Profitability Analysis
The company reported the revenue of 1.53 B. Net Income was 58.97 M with profit before overhead, payroll, taxes, and interest of 1.68 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Double Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Double Medical and how it compares across the competition.
About Double Medical Valuation
The stock valuation mechanism determines Double Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Double Medical. We calculate exposure to Double Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Double Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1 B | 1.1 B |
Double Medical Quarterly Retained Earnings |
|
Complementary Tools for Double Stock analysis
When running Double Medical's price analysis, check to measure Double Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Double Medical is operating at the current time. Most of Double Medical's value examination focuses on studying past and present price action to predict the probability of Double Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Double Medical's price. Additionally, you may evaluate how the addition of Double Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |